GPT and metabolic dysfunction-associated steatohepatitis: Maximos et al. assessed underlying factors of plasma ALT elevations in patients with biopsy-proven NAFLD/NASH, and showed that adipose tissue insulin resistance and liver triglyceride content are majors factors for elevated plasma aminotransferase levels [43].